Please login to the form below

Not currently logged in
Email:
Password:

TAK-003

This page shows the latest TAK-003 news and features for those working in and with pharma, biotech and healthcare.

Takeda’s dengue vaccine receives MHRA approval for those aged four years and older

Takeda’s dengue vaccine receives MHRA approval for those aged four years and older

Takeda’s dengue vaccine, Qdenga (TAK-003), has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for those aged four years and older, the company announced.

Latest news

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...